These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32448111)

  • 1. Recent Advances in Herbal Nanomedicines for Cancer Treatment.
    Pradhan D; Biswasroy P; Sahu A; Sahu DK; Ghosh G; Rath G
    Curr Mol Pharmacol; 2021; 14(3):292-305. PubMed ID: 32448111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview.
    Teja PK; Mithiya J; Kate AS; Bairwa K; Chauthe SK
    Phytomedicine; 2022 Feb; 96():153890. PubMed ID: 35026510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalization of curcumin nanomedicines: a recent promising adaptation to maximize pharmacokinetic profile, specific cell internalization and anticancer efficacy against breast cancer.
    Zhang J; Sun J; Li C; Qiao H; Hussain Z
    J Nanobiotechnology; 2023 Mar; 21(1):106. PubMed ID: 36964547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers for anticancer drugs--new trends in nanomedicine.
    Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
    Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology and curcumin: a novel and promising approach in digestive cancer therapy.
    Zhang Y; Li Z; Huang Y; Xu Y; Zou B
    Nanomedicine (Lond); 2023 Nov; 18(27):2081-2099. PubMed ID: 38078442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.
    Hock SC; Ying YM; Wah CL
    PDA J Pharm Sci Technol; 2011; 65(2):177-95. PubMed ID: 21502077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
    Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
    J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PhytoNanotechnology: Enhancing Delivery of Plant Based Anti-cancer Drugs.
    Khan T; Gurav P
    Front Pharmacol; 2017; 8():1002. PubMed ID: 29479316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Nanomedicines for Cancer Treatment.
    do Nascimento T; Todeschini AR; Santos-Oliveira R; de Souza de Bustamante Monteiro MS; de Souza VT; Ricci-Júnior E
    Curr Pharm Des; 2020; 26(29):3579-3600. PubMed ID: 32186271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology-applied curcumin for different diseases therapy.
    Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
    Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in nanotechnology-based delivery systems for curcumin.
    Sun M; Su X; Ding B; He X; Liu X; Yu A; Lou H; Zhai G
    Nanomedicine (Lond); 2012 Jul; 7(7):1085-100. PubMed ID: 22846093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy.
    Verma R; Rao L; Nagpal D; Yadav M; Kumar V; Kumar V; Kumar H; Parashar J; Bansal N; Kumar M; Pandey P; Mittal V; Kaushik D
    Recent Pat Nanotechnol; 2024; 18(4):395-414. PubMed ID: 37537775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review.
    Gorain B; Karmakar V; Sarkar B; Dwivedi M; Leong JTL; Toh JH; Seah E; Ling KY; Chen KY; Choudhury H; Pandey M
    Int J Biol Macromol; 2023 Dec; 253(Pt 1):126623. PubMed ID: 37657573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
    Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
    Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Robust Microfluidic Technology and New Lipid Composition for Fabrication of Curcumin-Loaded Liposomes: Effect on the Anticancer Activity and Safety of Cisplatin.
    Hamano N; Böttger R; Lee SE; Yang Y; Kulkarni JA; Ip S; Cullis PR; Li SD
    Mol Pharm; 2019 Sep; 16(9):3957-3967. PubMed ID: 31381352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
    Ozeki T; Tagami T
    Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
    Ruttala HB; Ko YT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Curcumin and Paclitaxel Liposomes Exhibits Enhanced Cytotoxicity Towards A549/A549-T Cells and Unaltered Pharmacokinetics.
    Feng X; Pi C; Fu S; Yang H; Zheng X; Hou Y; Wang Y; Zhang X; Zhao L; Wei Y
    J Biomed Nanotechnol; 2020 Aug; 16(8):1304-1313. PubMed ID: 33397559
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in curcumin nanoformulation for cancer therapy.
    Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
    Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paclitaxel drug delivery systems.
    Zhang Z; Mei L; Feng SS
    Expert Opin Drug Deliv; 2013 Mar; 10(3):325-40. PubMed ID: 23289542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.